PCIを受ける急性心筋梗塞（AMI）患者の予後評価における、早期血栓形成分子の新規4マーカーおよびトロンボエラストグラフィーの役割

Sun ら（Wed,）はこの問題を研究した。

www.synapsesocial.com/papers/69b4fc6ab39f7826a300d4aa — DOI: https://doi.org/10.1186/s43044-026-00728-5

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Standardized Bleeding Definitions for Cardiovascular Clinical Trials· 2011 · 4,385 citations
2. Protective roles of thrombomodulin in cisplatin-induced nephrotoxicity through the inhibition of oxidative and endoplasmic reticulum stress· 2024 · 11 citations
3. Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial· 2024 · 22 citations
4. Performance evaluation of thrombomodulin, thrombin‐antithrombin complex, plasmin‐α2‐antiplasmin complex, and t‐PA: PAI‐1 complex· 2019 · 26 citations
5. Corrigendum to “Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients” [Thromb. Res. 186 2020. 80–85]· 2021 · 6 citations